{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:06:13Z","timestamp":1788951973976,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011493","name":"Taizhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["23ywa19"],"award-info":[{"award-number":["23ywa19"]}],"id":[{"id":"10.13039\/501100011493","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clbc.2026.07.027","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T22:08:42Z","timestamp":1785103722000},"page":"154-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CTSG Suppresses Breast Cancer Progression by Inhibiting the EGFR\/ERK Signaling Pathway and Enhancing CD8\u207a T Cell Activation"],"prefix":"10.1016","volume":"26","author":[{"given":"Yue","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2026.07.027_bib0001","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/0118744710254730231114181358","article-title":"Impact of radiation therapy on serum humanin and MOTS-c levels in patients with lung or breast cancer","volume":"17","author":"Ayse G\u00fclbin","year":"2024","journal-title":"Curr Radiopharmaceut"},{"key":"10.1016\/j.clbc.2026.07.027_bib0002","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.2174\/0115701808255183230922110002","article-title":"Construction of prognostic ceRNA network landscape in breast cancer to explore impacting genes on drug response by integrative bioinformatics analysis","volume":"21","author":"Mahboubeh","year":"2024","journal-title":"Lett Drug Design Discov"},{"key":"10.1016\/j.clbc.2026.07.027_bib0003","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.2174\/0115701808333132241226071319","article-title":"Deciphering the multi-target pharmacological mechanism of Sojae Semen Nigrum acting on breast cancer through integrating network pharmacology and molecular docking approaches","volume":"21","author":"Jiangqin","year":"2024","journal-title":"Lett Drug Design Discov"},{"key":"10.1016\/j.clbc.2026.07.027_bib0004","first-page":"1","article-title":"Anticancer properties of Baicalin against breast cancer and other gynecological cancers: therapeutic opportunities based on underlying mechanisms","volume":"17","author":"Mohammad Hossein","year":"2024","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.clbc.2026.07.027_bib0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-024-01649-z","article-title":"Current and future immunotherapy for breast cancer","volume":"17","author":"Heater","year":"2024","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.clbc.2026.07.027_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-031-66686-5_1","article-title":"MDIG in breast cancer progression and metastasis","volume":"1465","author":"Thakur","year":"2024","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.clbc.2026.07.027_bib0007","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3892\/ijmm.2024.5388","article-title":"Public neoantigens in breast cancer immunotherapy (Review)","volume":"54","author":"Sueangoen","year":"2024","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.clbc.2026.07.027_bib0008","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12935-025-03944-2","article-title":"Integration of multi-omics approaches in exploring intra-tumoral heterogeneity","volume":"25","author":"Dong","year":"2025","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.clbc.2026.07.027_bib0009","doi-asserted-by":"crossref","DOI":"10.1177\/11795549251384582","article-title":"Navigating cancer complexity: integrative Multi-omics methodologies for clinical insights","volume":"19","author":"Catalano","year":"2025","journal-title":"Clin Med Insights Oncol"},{"key":"10.1016\/j.clbc.2026.07.027_bib0010","first-page":"543","article-title":"Identification of a ubiquitination-related signature for ovarian cancer based on 101 combinations of machine learning methods","volume":"21","author":"Miao","year":"2024","journal-title":"Curr Proteomics"},{"key":"10.1016\/j.clbc.2026.07.027_bib0011","first-page":"392","article-title":"Molecular mechanisms of antiproliferative effects of Safranal on cervical cancer: evidence from bioinformatics analysis","volume":"21","author":"Souandaou Athoumani","year":"2024","journal-title":"Curr Proteomics"},{"key":"10.1016\/j.clbc.2026.07.027_bib0012","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41467-020-14367-0","article-title":"Pathway and network analysis of more than 2500 whole cancer genomes","volume":"11","author":"Reyna","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.clbc.2026.07.027_bib0013","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1016\/j.cell.2024.05.039","article-title":"Pan-cancer proteogenomics expands the landscape of therapeutic targets","volume":"187","author":"Savage","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.clbc.2026.07.027_bib0014","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201885","article-title":"Antibody reliability influences observed mRNA-protein correlations in tumour samples","volume":"6","author":"Upadhya","year":"2023","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.clbc.2026.07.027_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202400107","article-title":"Parallel analyses by mass spectrometry (MS) and reverse phase protein array (RPPA) reveal complementary proteomic profiles in triple-negative breast cancer (TNBC) patient tissues and cell cultures","volume":"25","author":"Wang","year":"2025","journal-title":"Proteomics"},{"key":"10.1016\/j.clbc.2026.07.027_bib0016","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s43018-024-00869-z","article-title":"Mapping the functional network of human cancer through machine learning and pan-cancer proteogenomics","volume":"6","author":"Shi","year":"2025","journal-title":"Nat Cancer"},{"key":"10.1016\/j.clbc.2026.07.027_bib0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00005-020-00585-3","article-title":"Cathepsin G and its dichotomous role in modulating levels of MHC class I molecules","volume":"68","author":"Burster","year":"2020","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.clbc.2026.07.027_bib0018","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00432-024-06051-3","article-title":"CTSG is a prognostic marker involved in immune infiltration and inhibits tumor progression though the MAPK signaling pathway in non-small cell lung cancer","volume":"151","author":"Dai","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.clbc.2026.07.027_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111562","article-title":"CTSG restraines the proliferation and metastasis of head and neck squamous cell carcinoma by blocking the JAK2\/STAT3 pathway","volume":"127","author":"Hua","year":"2025","journal-title":"Cell Signal"},{"key":"10.1016\/j.clbc.2026.07.027_bib0020","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.7150\/ijbs.82000","article-title":"CTSG suppresses colorectal cancer progression through negative regulation of akt\/mTOR\/Bcl2 signaling pathway","volume":"19","author":"Chan","year":"2023","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.clbc.2026.07.027_bib0021","article-title":"Neutrophil extracellular traps induced by chemotherapy inhibit tumor growth in murine models of colorectal cancer","volume":"134","author":"Li","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clbc.2026.07.027_bib0022","first-page":"110","article-title":"CRISPR\/Cas9 screenings reveal the role of STX1A and CDK1 in Cathepsin G entering and killing colorectal cancer cells","volume":"31","author":"Wang","year":"2025","journal-title":"Interdiscip Inf Sci"},{"key":"10.1016\/j.clbc.2026.07.027_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112616","article-title":"Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development","volume":"147","author":"Zhang","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.clbc.2026.07.027_bib0024","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.biopha.2016.10.018","article-title":"Multiple molecular targets in breast cancer therapy by betulinic acid","volume":"84","author":"Luo","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.clbc.2026.07.027_bib0025","doi-asserted-by":"crossref","first-page":"9360","DOI":"10.3390\/ijms24119360","article-title":"The mechanism of DNA methylation and miRNA in breast cancer","volume":"24","author":"Ma","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clbc.2026.07.027_bib0026","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/0113892010303244240718075729","article-title":"Recent advances in immunotherapy and targeted therapy of triple negative breast cancer","volume":"26","author":"Shewale","year":"2025","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.clbc.2026.07.027_bib0027","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cancergen.2025.08.010","article-title":"Comprehensive analysis of oncogenic determinants across tumor types via multi-omics integration","volume":"298-299","author":"Ubaid","year":"2025","journal-title":"Cancer Genet"},{"key":"10.1016\/j.clbc.2026.07.027_bib0028","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/s41588-025-02351-7","article-title":"Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer","volume":"57","author":"Aung","year":"2025","journal-title":"Nat Genet"},{"key":"10.1016\/j.clbc.2026.07.027_bib0032","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11033-024-10144-0","article-title":"DNA hypermethylation of tumor suppressor genes among oral squamous cell carcinoma patients: a prominent diagnostic biomarker","volume":"52","author":"Agarwal","year":"2024","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.clbc.2026.07.027_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102098","article-title":"Identification of a biomarker to predict doxorubicin\/cisplatin chemotherapy efficacy in osteosarcoma patients using primary, recurrent and metastatic specimens","volume":"49","author":"Ma","year":"2024","journal-title":"Transl Oncol"},{"key":"10.1016\/j.clbc.2026.07.027_bib0034","article-title":"SERPINA3 mediates liver cancer cells escape from chemotherapy-induced neutrophil extracellular trap killing","volume":"45","author":"Zhang","year":"2026","journal-title":"Cell Rep"},{"key":"10.1016\/j.clbc.2026.07.027_bib0035","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.21873\/anticanres.17013","article-title":"Investigation of genetic association between a high activity variant of Cathepsin G and risk for basal cell carcinoma","volume":"44","author":"Douka","year":"2024","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clbc.2026.07.027_bib0036","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi1328","article-title":"Piezo1 activates noncanonical EGFR endocytosis and signaling","volume":"9","author":"Pardo-Pastor","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.clbc.2026.07.027_bib0037","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12964-024-01797-2","article-title":"Involvement of HDAC2-mediated kcnq2\/kcnq3 genes transcription repression activated by EREG\/EGFR-ERK-Runx1 signaling in bone cancer pain","volume":"22","author":"Zhang","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.clbc.2026.07.027_bib0038","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3390\/cells13201733","article-title":"AREG upregulation in cancer cells via direct interaction with cancer-associated fibroblasts promotes esophageal squamous cell carcinoma progression through EGFR-Erk\/p38 MAPK signaling","volume":"13","author":"Nakanishi","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.clbc.2026.07.027_bib0039","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41419-023-05911-z","article-title":"Stanniocalcin 1 promotes lung metastasis of breast cancer by enhancing EGFR-ERK-S100A4 signaling","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.clbc.2026.07.027_bib0040","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13027-024-00599-y","article-title":"CTSG may inhibit disease progression in HIV-related lung cancer patients by affecting immunosuppression","volume":"19","author":"Yan","year":"2024","journal-title":"Infect. Agent Cancer"},{"key":"10.1016\/j.clbc.2026.07.027_bib0041","article-title":"Cathepsin G-induced malignant progression of MCF-7 cells involves suppression of PAF signaling through induced expression of PAFAH1B2","volume":"1867","author":"Tanigawa","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.clbc.2026.07.027_bib0042","doi-asserted-by":"crossref","DOI":"10.1093\/tropej\/fmae017","article-title":"CTSG polymorphisms in Chinese children with type 1 diabetes mellitus","volume":"70","author":"Li","year":"2024","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.clbc.2026.07.027_bib0043","article-title":"Identification of lysosome-related genes in connection with prognosis and immune cell infiltration for drug candidates in head and neck cancer","volume":"18","author":"Shen","year":"2023","journal-title":"Open Life Sci"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:07:23Z","timestamp":1788948443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926001291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1526820926001291"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.07.027","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CTSG Suppresses Breast Cancer Progression by Inhibiting the EGFR\/ERK Signaling Pathway and Enhancing CD8\u207a T Cell Activation","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}